Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cash Flow from Operations

Akebia Therapeutics Cash Flow from Operations Chart (AKBA)

Akebia Therapeutics annual/quarterly Cash Flow from Operations from 2012 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending June 06, 2020 was $37m a 70.48% increase of 26m year over year
  • Akebia Therapeutics Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-134m a -79.01% increase of 105m year over year
  • Akebia Therapeutics Annual Cash Flow from Operations for 2019 was $-257m a 62.13% decrease of -160m from 2018
  • Akebia Therapeutics Annual Cash Flow from Operations for 2018 was $-97m a 42.40% decrease of -41m from 2017
  • Akebia Therapeutics Annual Cash Flow from Operations for 2017 was $-56m a 203.11% decrease of -114m from 2016
Other Cash Flow Metrics:
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Cash Flow from Operations Data

06/2020$37m
03/2020$-90m
12/2019$-92m
09/2019$11m
06/2019$-38m
03/2019$-138m
12/2018$-74m
09/2018$-12m
06/2018$9m
03/2018$-20m

Annual AKBA Cash Flow from Operations Data

2019$-257m
2018$-97m
2017$-56m
2016$58m
2015$-52m
2014$-27m
2013$-11m
2012$-7m
2011$-14m